Centene Corp (CNC) is a good buy for a beginner investor with a long-term strategy and $50,000-$100,000 available for investment. The stock has positive analyst sentiment, recent congressional purchases, and a stable technical setup with bullish moving averages. Despite some negative catalysts, the long-term growth potential and favorable analyst price targets make it a strong candidate for investment.
The stock's MACD is negative and expanding (-0.786), indicating bearish momentum. RSI is neutral at 40.797, suggesting no overbought or oversold conditions. However, moving averages are bullish (SMA_5 > SMA_20 > SMA_200), and the stock is trading near its key support level (S1: 60.746), which could provide a solid entry point.

Positive analyst sentiment with multiple price target upgrades, including a high target of $
Congressional purchase of $0.8M, indicating confidence in the stock.
Recent initiatives like the MHS Workforce Support Program and affordable housing projects demonstrate the company's commitment to social impact and long-term growth.
Employee buyout program due to revenue losses from declining Obamacare membership, with a 6% decrease in health plan members year-over-year.
MACD indicates bearish momentum, and the stock has an 80% chance of a slight decline (-2.09%) in the next day.
Financial data is unavailable for the latest quarter, but analysts indicate favorable Q1 medical cost trends and muted cost trends in Q2, suggesting stability in the company's financials.
Analysts are largely bullish on Centene, with multiple Buy ratings and price target upgrades. Key highlights include Deutsche Bank's upgrade to Buy with an $80 target and Barclays' Overweight rating with a $75 target. The consensus reflects optimism about the company's margin recovery and long-term earnings potential.